Kevin Alby

2.2k total citations
55 papers, 1.6k citations indexed

About

Kevin Alby is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Kevin Alby has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 22 papers in Infectious Diseases and 14 papers in Molecular Medicine. Recurrent topics in Kevin Alby's work include Antibiotic Resistance in Bacteria (14 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antifungal resistance and susceptibility (12 papers). Kevin Alby is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antifungal resistance and susceptibility (12 papers). Kevin Alby collaborates with scholars based in United States, Botswana and Canada. Kevin Alby's co-authors include Richard J. Bennett, Melissa B. Miller, Judith Berman, Anja Forche, Alexander D. Johnson, Peter H. Gilligan, Ted M. Ross, Benjamin S. Chambers, Kaela Parkhouse and Scott E. Hensley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Kevin Alby

53 papers receiving 1.6k citations

Peers

Countries citing papers authored by Kevin Alby

Since Specialization

Citations

This map shows the geographic impact of Kevin Alby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Alby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Alby more than expected).

Fields of papers citing papers by Kevin Alby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Alby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Alby. The network helps show where Kevin Alby may publish in the future.

Co-authorship network of co-authors of Kevin Alby

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Alby. A scholar is included among the top collaborators of Kevin Alby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Alby. Kevin Alby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P-258. A Longitudinal Study on the Impact of Sink Interventions on Environmental Bioburden and Patient Infections within Two Intensive Care Units at an Academic Hospital 2025 ·Open Forum Infectious Diseases ·(unknown), Emily Sickbert-Bennett, (unknown), (unknown), (unknown), (unknown), Kevin Alby, (unknown), (unknown), Lauren DiBiase, (unknown), Becky Smith, Deverick J. Anderson, David J. Weber	0
2	Evaluation of Piperacillin-Tazobactam Testing against Enterobacterales by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute Breakpoints 2023 ·Journal of Clinical Microbiology ·(unknown), (unknown), April N. Abbott, (unknown), Kevin Alby, (unknown), Jennifer Dien Bard, (unknown), (unknown), Amanda Harrington, (unknown), Amy J. Mathers, Tsigereda Tekle, Patricia J. Simner, Romney M. Humphries	9
3	Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022 2023 ·Journal of Clinical Microbiology ·Jean B. Patel, Kevin Alby, Romney M. Humphries, Melvin P. Weinstein, Joseph D. Lutgring, Samia N. Naccache, Patricia J. Simner	10
4	Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post–acute-care setting 2022 ·Infection Control and Hospital Epidemiology ·Helen L. Zhang, (unknown), Jennifer Han, Kevin Alby, Zena Lapp, Evan S. Snitkin, Ellie J. C. Goldstein, Sean R. Muldoon, Pam Tolomeo, Ebbing Lautenbach	3
5	Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study 2022 ·International Journal of Infectious Diseases ·(unknown), (unknown), Robert A. Gross, Rachel M. Smith, Kevin Alby, Laurel Glaser, Melissa Richard‐Greenblatt, Rebekah E. Dumm, Aditya Sharma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giacomo Maria Paganotti, Margaret Mokomane, Ebbing Lautenbach	18
6	Association of Obesity With Maternal and Cord Blood Penicillin Levels in Women With Group B Streptococcus Colonization 2020 ·Obstetrics and Gynecology ·(unknown), Michal A. Elovitz, Kevin Alby, Nathanael Koelper, Itzhak Nissim, Lisa D. Levine	6
7	The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis 2019 ·Journal of Cystic Fibrosis ·Gina Hong, Kevin Alby, (unknown), (unknown), (unknown), Ronald C. Rubenstein, Daniel Dorgan, Steven M. Kawut, Denis Hadjiliadis	27
8	Lower Respiratory Multiplex Panels for the Detection of Bacterial and Viral Infections 2018 ·Clinical Microbiology Newsletter ·Kevin Alby, Stephanie L. Mitchell	11
9	Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results 2018 ·Infection Control and Hospital Epidemiology ·Matthew J. Ziegler, Daniel J. Landsburg, David A. Pegues, Kevin Alby, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pam Tolomeo, Jennifer Han	11
10	Performance of microbial identification by MALDI-TOF MS and susceptibility testing by VITEK 2 from positive blood cultures after minimal incubation on solid media 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Kevin Alby	11
11	Successful treatment of a disseminated infection with extensively drug‐resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin‐based multidrug regimen 2016 ·Transplant Infectious Disease ·John Mills, Marissa B. Wilck, (unknown), Paige M. Porrett, (unknown), Kevin Alby, Robert A. Bonomo, Emily A. Blumberg	13
12	The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents 2015 ·Infection Control and Hospital Epidemiology ·John Mills, Naasha J Talati, Kevin Alby, Jennifer Han	45
13	Improved surveillance for carbapenem-resistant Enterobacteriaceae using chromogenic media with a broth enrichment 2015 ·Diagnostic Microbiology and Infectious Disease ·Laurel Glaser, (unknown), (unknown), Kevin Alby	13
14	Clinical Outcomes with Rapid Detection of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates from Routine Blood Cultures 2013 ·Journal of Clinical Microbiology ·(unknown), (unknown), Kevin Alby, Jeffrey P. Laux, Feng‐Chang Lin, (unknown), David J. Weber, Melissa B. Miller	16
15	Discovery of a phenotypic switch regulating sexual mating in the opportunistic fungal pathogen Candida tropicalis 2011 ·Proceedings of the National Academy of Sciences ·Allison M. Porman, Kevin Alby, Matthew P. Hirakawa, Richard J. Bennett	102
16	Interspecies pheromone signaling promotes biofilm formation and same-sex mating in Candida albicans 2011 ·Proceedings of the National Academy of Sciences ·Kevin Alby, Richard J. Bennett	46
17	Stress-Induced Phenotypic Switching in Candida albicans 2009 ·Molecular Biology of the Cell ·Kevin Alby, Richard J. Bennett	101
18	To Switch or Not to Switch? Phenotypic switching is sensitive to multiple inputs in a pathogenic fungus 2009 ·Communicative & Integrative Biology ·Kevin Alby, (unknown)	7
19	Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans 2009 ·Nature ·Kevin Alby, (unknown), Richard J. Bennett	157
20	The Parasexual Cycle in Candida albicans Provides an Alternative Pathway to Meiosis for the Formation of Recombinant Strains 2008 ·PLoS Biology ·Anja Forche, Kevin Alby, (unknown), Alexander D. Johnson, Judith Berman, Richard J. Bennett	249

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact